[Update] PB Fintech Crashes 36%, Turtlemint 20% On IRDAI Commission Cap Plan

Update | September 24, 16:34 IST

Shares of PB Fintech ended today’s trading session 35.98% lower at ₹1,210 apiece on the BSE, hitting the dynamically revised lower price band. The company’s market capitalisation stood at ₹55,993.08 Cr ($5.8 Bn) at the end of the session.

Meanwhile, Turtlemint shares remained locked at the lower circuit, ending 19.99% down at ₹109.10 apiece.

Original | September 24, 11: 27 IST

Shares of Policybazaar parent PB Fintech and insurtech company Turtlemint crashed after the Insurance Regulatory and Development Authority of India (IRDAI) proposed a sweeping overhaul of insurance distribution, including hard commission caps and lower expenses of management (EoM) limits.

PB Fintech shares plunged 26% to ₹1,398.60 on the BSE, hitting the dynamically revised lower price band. The stock opened 10.1% lower at ₹1,700 and continued to slide during intraday trading.

At ₹1,398.60, PB Fintech’s market capitalisation stood at ₹64,720.6 Cr (about $6.7 Bn). 

Meanwhile, Turtlemint shares hit their 20% lower circuit of ₹109.10, which was also the stock’s all-time low. The company’s market cap fell to ₹3,212.8 Cr (about $333 Mn).

The sell-off followed the release of IRDAI’s consultation paper yesterday, which proposed recalibrating the economics of insurance distribution by lowering commissions and insurer expenses, increasing transparency, and tightening accountability for distributors.

Among the most significant changes, IRDAI has proposed nil commission for insurance distribution entities on third-party insurance for new vehicles and a 5% cap on new-vehicle own-damage, personal accident, and legal liability covers. 

For individual health insurance, the regulator has proposed capping commissions for distribution entities at 15% of the premium on first-time sales and 5% on renewals and portability.

The proposed caps are significant as IRDAI’s paper said average motor insurance commissions currently stand at 24%, with rates ranging from 13% to 50%.

IRDAI has also proposed restricting the EoM of life insurers to 15% of premiums within two years and 12.5% within five years. For general insurers, the regulator has proposed lowering the limit to 25% within two years and 20% within five years.

The regulator has sought stakeholder comments on the proposals by October 25.

The proposed restrictions have long been an overhang for PB Fintech. Chairman Yashish Dahiya warned earlier that hard commission caps could pose an existential threat to insurance distributors such as Policybazaar, adding that the company could evaluate securing an insurance manufacturing licence to design and underwrite policies directly.

Brokerages Flag Pressure On Insurance Distribution Economics

Brokerages warned that the proposed changes could significantly compress insurance distribution economics, with PB Fintech emerging as one of the most exposed companies.

Bernstein said the proposed commission cuts are much steeper than anticipated and could unravel PB Fintech’s unit economics under the proposed take-rate caps, particularly in health and motor insurance. It also flagged the possibility of commission deferrals in term insurance.

For insurers, the brokerage expects some drag on health and term insurance growth. While lower distribution costs could eventually translate into cheaper policies and higher volumes, Bernstein believes this may not be enough to structurally offset commission-driven sales volumes in a push-product category such as insurance.

The brokerage also expects strong industry pushback against the proposals, with near-term market action likely to reflect the potential impact on PB Fintech.

Macquarie flagged the proposed tightening of EoM limits and said the proposals favour tied agents over bancassurance and broker channels, potentially rewarding selling effort over distribution leverage.

It identified PB Fintech as the most exposed company, while saying LIC and SBI Life could be relatively insulated.

HSBC described the proposed EoM limits as stringent and said they could have wide-ranging implications for insurers, brokers, and lenders. It expects SBI Life to be relatively less affected, while HDFC Life, Max Financial Services, and PB Fintech could face a greater impact.

Jefferies estimates that the proposed commission caps could result in cuts of one-half to one-third in health, term and motor insurance commissions. A 10% reduction in new business commission rates, it said, could translate into a 10-12% decline in earnings for PB Fintech and Turtlemint.

The brokerage further noted that any correction in SBI Life, Star Health and ICICI General Insurance could offer buying opportunities, given the relatively limited risks from the consultation paper and potential market share gains.

Citi, too, warned that the proposed commission caps could significantly tighten distribution economics, particularly in high-margin categories. It estimates that distribution economics could compress 70-90% across several such categories if the proposals are implemented as drafted.

The brokerage highlighted credit-linked insurance as a particularly vulnerable category, saying existing commissions are often several times higher than the proposed caps. It said payouts for group credit life insurance have risen to nearly 45%, while commissions in NBFC-led channels average around 42%. 

The proposed ban on mandatory insurance bundling with loans and credit could further disrupt existing distribution models. The draft also proposes restrictions on incentives, rewards, gifts, trips and related-party payment.

The post [Update] PB Fintech Crashes 36%, Turtlemint 20% On IRDAI Commission Cap Plan appeared first on Inc42 Media.